Compass Pathways (CMPS) stock rises as the company posts new late-stage trial data for its psychedelic therapy COMP360 ...
Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT, the "Company"), a clinical-stage biotechnology company advancing a novel ...
The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...
In an interview, synthetic biologist Peter Carr explains research on synthetic cells, their potential benefits and hazards, ...
Alpha Tau Medical (DRTS) pioneers alpha emitter-based targeted radiation therapy, aiming for highly localized tumor ...
The finalists will take the stage at electronica 2026 (10 to 13 November in Munich, Germany) present their solutions and compete for the main prize on 13 November. What if the device in your pocket ...
Award presented to GM wheat genetic engineer Raquel Chan in Paris has reignited doubts about the crop and the technology. Report: Claire Robinson ...
More than a year after Vietnam began implementing Resolution 57, new innovation models are emerging nationwide while ...
NORTH CHICAGO, Ill. and SAN FRANCISCO and BOSTON, June 22, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Apogee Therapeutics (NASDAQ: APGE) ("Apogee") today announced they have entered into a ...
After spending nearly Rs 6,800 crore and more than two decades, Wockhardt has achieved what no Indian pharmaceutical company ...
IntraBio Inc. today announced that results from its pivotal Phase III clinical trial evaluating levacetylleucine for the treatment of Ataxia-Telangiectasia (A-T) have been published in The Lancet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results